Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts

摘要

Disclosed is the use of a 2-phenyl-3-aroyl[b]benzothiophene (ie raloxifen) and a bisphonate (ie etidronate, clodronate, pamidronate, alendronate, residronate or tiludonate) in the preparation of medicaments for inhibiting bone loss.